Description:
Executive Summary: "Following 19 months of consultation and eight interim papers,
each focusing on a specific aspect of antimicrobial resistance
(AMR), this report sets out the Review on Antimicrobial
Resistance?s final recommendations to tackle AMR in a global
way, as commissioned by our sponsors, the UK Government
and the Wellcome Trust.
The magnitude of the problem is now accepted. We estimate
that by 2050, 10 million lives a year and a cumulative 100 trillion
USD of economic output are at risk due to the rise of drugresistant
infections if we do not find proactive solutions now
to slow down the rise of drug resistance. Even today, 700,000
people die of resistant infections every year. Antibiotics are a
special category of antimicrobial drugs that underpin modern
medicine as we know it: if they lose their effectiveness, key
medical procedures (such as gut surgery, caesarean sections, joint
replacements, and treatments that depress the immune system,
such as chemotherapy for cancer) could become too dangerous
to perform. Most of the direct and much of the indirect impact of
AMR will fall on low and middle‑income countries.
It does not have to be this way. It is in policy makers and
governments? hands to take steps to change this situation..."
Source/publisher:
The Review on Antimicrobial Resistance
Date of Publication:
2016-05-00
Date of entry:
2016-08-16
Grouping:
- Individual Documents
Category:
Language:
English
Local URL:
Format:
pdf
Size:
2.26 MB